Prostate Cancer Prognosis
Prostate Cancer prognosis involves the staging of prostate cancer. Furthermore, it refers to the extent of the disease at the time of diagnosis. Staging is one of the most important factors that doctors consider when analyzing prostate cancer survival rates and prognosis. It also helps in selecting the best treatment options that the hospital will administer to the patient. (1)
Staging depends on the following factors:
- The blood PSA level at the time of diagnosis
- The prostate biopsy results
- The results from any other tests to find out if the cancer has metastasized to other tissues in the body.
The staging system helps the cancer care team to describe the extent to which cancer has spread. Additionally, the most widely used staging system is the one American Joint Committee on Cancer (AJCC) provided.
It contains five key pieces which are:
- Tumor: Describes the size of the primary tumor and whether it has metastasized outside the prostate
- Node: This, on the other hand, the spread of cancer to the nearby lymph nodes; which are immune system cells that cancer affects first.
- Metastasis: Describes whether the cancer has metastasized to other body organs
- The PSA level at the time of diagnosis; lastly,
- The Gleason score, based on the surgery
TNM Stage Grouping
The T, N, M categories help determine the overall stage of the patient’s cancer. It is a major factor considered in breast cancer survival rates and prognosis. Additionally, these stages range from stage 0 to IV with letters further categorizing them. Additionally, the names of these steps depend on the area affected by the tumor and the size of the tumor. (2)
Furthermore, prostate cancer survival rates and prognosis helps in identifying the right treatment doctors will administer and the general outlook of the patient.
Prostate Cancer Survival Rates
Survival rates help to understand what percentage of people with prostate cancer in the same stage and type of cancer are still alive. Furthermore, doctors use it as a standard way of determining one’s prognosis. Hence, it is one of the most significant cancer survival rates and prognosis factor for them to consider. (3)
Physicians state the prognosis as the outlook of the person in 5 years time. The survival rate also depends on the type of cancer the person has. Lastly, the survival rates are expressed as a percentage.
Relative survival rates: These are a more accurate way to estimate the effect of cancer on survival. It compares the men with prostate cancer to men in the overall population. The relative survival rates are expressed as a percentage. They include:
- The 5-year relative survival rate is 99%
- The 10-year relative survival rate is 98%
- The 15-year relative survival rate is 96%
Survival rates are also done by staging, and these stages include:
- Local stage: In this juncture, there are no signs that the cancer has spread to other tissues. The 5-year survival rate is nearly 100%
- Regional stage: In this stage, the cancer has spread to the nearby tissues from the prostate. The 5-year survival rate is approximately 100%.
- Distant stage: Lastly, this is the stage in which the cancer has spread to the distant lymph nodes, bones or other body organs. The 5-year survival rate is about 29%.